- Home
- ASND vs TAP Comparison
ASND vs TAP Comparison
Compare ASND & TAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- TAP
- Stock Information
- Founded
- ASND 2006
- TAP 1873
- Country
- ASND Denmark
- TAP United States
- Employees
- ASND N/A
- TAP N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- TAP Beverages (Production/Distribution)
- Sector
- ASND Health Care
- TAP Consumer Staples
- Exchange
- ASND Nasdaq
- TAP Nasdaq
- Market Cap
- ASND 10.6B
- TAP 10.7B
- IPO Year
- ASND 2015
- TAP N/A
- Fundamental
- Price
- ASND $170.86
- TAP $48.10
- Analyst Decision
- ASND Strong Buy
- TAP Hold
- Analyst Count
- ASND 16
- TAP 13
- Target Price
- ASND $218.19
- TAP $57.62
- AVG Volume (30 Days)
- ASND 435.4K
- TAP 2.6M
- Earning Date
- ASND 05-01-2025
- TAP 08-05-2025
- Dividend Yield
- ASND N/A
- TAP 3.96%
- EPS Growth
- ASND N/A
- TAP N/A
- EPS
- ASND N/A
- TAP 4.99
- Revenue
- ASND $398,509,511.00
- TAP $11,334,700,000.00
- Revenue This Year
- ASND $75.05
- TAP N/A
- Revenue Next Year
- ASND $78.14
- TAP $0.90
- P/E Ratio
- ASND N/A
- TAP $9.50
- Revenue Growth
- ASND 12.06
- TAP N/A
- 52 Week Low
- ASND $111.09
- TAP $46.94
- 52 Week High
- ASND $183.00
- TAP $64.66
- Technical
- Relative Strength Index (RSI)
- ASND 52.37
- TAP 27.64
- Support Level
- ASND $166.84
- TAP $46.94
- Resistance Level
- ASND $180.78
- TAP $48.74
- Average True Range (ATR)
- ASND 5.57
- TAP 0.95
- MACD
- ASND -0.53
- TAP -0.07
- Stochastic Oscillator
- ASND 38.59
- TAP 20.63
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About TAP Molson Coors Beverage Company Class B
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.